Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S288502-10mg | 10mg | In stock | $140.90 | |
S288502-50mg | 50mg | In stock | $543.90 | |
S288502-100mg | 100mg | In stock | $979.90 | |
S288502-250mg | 250mg | In stock | $2,203.90 |
Potent and selective A1antagonist
Synonyms | SLV320 | SLV-320 | SB52662 | AS-38714 | J-015863 | SCHEMBL2832387 | starbld0043651 | TRANS-4-((2-PHENYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)CYCLOHEXANOL | 4-((2-Phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexan-1-ol | 4-[(2-phenyl-7H-pyrrolo[2,3-d |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Potent and selective adenosine A1receptor antagonist (Kivalues are 1, 200, 398 and 3981 nM at human A1, A3, A2Aand A2Breceptors respectively). Suppresses cardiac fibrosis and attenuates albuminuria, without effect on blood pressure in animal models of chr |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of A 1 receptor;Antagonist of A 2A receptor;Antagonist of A 2B receptor;Antagonist of A 3 receptor |
Product Description | Introduction: Derenofylline (SLV 320) is a potent, selective and orally active adenosine A1 receptor antagonist, with Ki values of 1 nM, 200 nM and 398 nM for human A1, A3 and A2A receptors respectively. Derenofylline suppresses cardiac fibrosis and attenuates albuminuria without affecting blood pressure in rats. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488196467 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488196467 |
IUPAC Name | 4-[(2-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexan-1-ol |
INCHI | InChI=1S/C18H20N4O/c23-14-8-6-13(7-9-14)20-18-15-10-11-19-17(15)21-16(22-18)12-4-2-1-3-5-12/h1-5,10-11,13-14,23H,6-9H2,(H2,19,20,21,22) |
InChi Key | RBZNJGHIKXAKQE-UHFFFAOYSA-N |
Canonical SMILES | C1CC(CCC1NC2=NC(=NC3=C2C=CN3)C4=CC=CC=C4)O |
Isomeric SMILES | C1CC(CCC1NC2=NC(=NC3=C2C=CN3)C4=CC=CC=C4)O |
RTECS | GW0775000 |
PubChem CID | 9953065 |
Molecular Weight | 308.38 |
CAS Registry No. | 251945-92-3 |
---|---|
PubChem CID | 9953065 |
GPCRdb Ligand | derenofylline |
PubChem SID | 488196467 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2317144 | Certificate of Analysis | Dec 08, 2022 | S288502 |
C2317160 | Certificate of Analysis | Dec 08, 2022 | S288502 |
C2317161 | Certificate of Analysis | Dec 08, 2022 | S288502 |
C2317163 | Certificate of Analysis | Dec 08, 2022 | S288502 |
C2317191 | Certificate of Analysis | Dec 08, 2022 | S288502 |
C2317200 | Certificate of Analysis | Dec 08, 2022 | S288502 |
C2317201 | Certificate of Analysis | Dec 08, 2022 | S288502 |
C2317203 | Certificate of Analysis | Dec 08, 2022 | S288502 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 30.84, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 15.42, Max Conc. mM: 50 |
---|
RTECS | GW0775000 |
---|---|
RIDADR | NONHforallmodesoftransport |